Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: A systematic review

Bhatnagar, 2015, The epidemiology of cardiovascular disease in the UK 2014, Heart, 101, 1182, 10.1136/heartjnl-2015-307516 British Heart Foundation, 2014 Montalescot, 2013, 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology, Eur. Heart J., 34, 2949, 10.1093/eurheartj/eht296 Cannon, 2000, Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction, JAMA, 283, 2941, 10.1001/jama.283.22.2941 Barbash, 2001, Circulation, 103, 954, 10.1161/01.CIR.103.7.954 Keeley, 2003, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet, 361, 13, 10.1016/S0140-6736(03)12113-7 Ross, 1999, Atherosclerosis–an inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207 Agrawal, 2013, Antiplatelet therapy: does prasugrel or ticagrelor suffice in patients with STEMI?, Nat. Rev. Cardiol., 10, 121, 10.1038/nrcardio.2012.199 Alexopoulos, 2013, Intrinsic platelet reactivity and thrombus burden in patients with ST-elevation myocardial infarction, Thromb. Res., 131, 333, 10.1016/j.thromres.2013.02.010 Angiolillo, 2008, Current antiplatelet therapies: benefits and limitations, Am. Heart J., 156, S3, 10.1016/j.ahj.2008.06.003 Steg, 2012, ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur. Heart J., 33, 2569, 10.1093/eurheartj/ehs215 1988, Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2.ISIS-2 (second international study of infarct survival) collaborative group, J. Am. Coll. Cardiol., 12, 3A Antithrombotic Trialists C, 2002, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients, BMJ, 324, 71, 10.1136/bmj.324.7329.71 Curzen, 2012, Antiplatelet therapy in acute coronary syndromes: beyond aspirin and clopidogrel, Heart, 98, 1617, 10.1136/heartjnl-2012-302299 Laine, 2015, COMparison of platelet reactivity following prAsugrel and ticagrelor loading dose in ST-segment elevation myocardial infarctION patients: the COMPASSION study, Platelets, 26, 570, 10.3109/09537104.2014.959914 Riegger, 2015, Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium dagger, Eur. Heart J. Contractor, 2012, Advances in antiplatelet therapy for acute coronary syndromes, Postgrad. Med. J., 88, 391, 10.1136/postgradmedj-2011-130539 Collet, 2009, Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study, Lancet, 373, 309, 10.1016/S0140-6736(08)61845-0 Tapp, 2010, Role of ticagrelor in clopidogrel nonresponders: resistance is futile?, Circulation, 121, 1169, 10.1161/CIR.0b013e3181d8d929 Hall, 2011, Antiplatelet drugs: a review of their pharmacology and management in the perioperative period, Anesth. Analg., 112, 292, 10.1213/ANE.0b013e318203f38d Brandt, 2007, A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation, Am. Heart J., 153, 66.e9, 10.1016/j.ahj.2006.10.010 Gurbel, 2009, Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study, Circulation, 120, 2577, 10.1161/CIRCULATIONAHA.109.912550 Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N. Engl. J. Med., 361, 1045, 10.1056/NEJMoa0904327 Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N. Engl. J. Med., 357, 2001, 10.1056/NEJMoa0706482 McNamara, 2006, Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction, J. Am. Coll. Cardiol., 47, 2180, 10.1016/j.jacc.2005.12.072 Society BCI, 2012, National Audit of Percutaneous Coronary Interventional Procedures Public Report Wiviott, 2007, Circulation, 116, 2923, 10.1161/CIRCULATIONAHA.107.740324 Shamseer, 2015, Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation, BMJ, 349, g7647, 10.1136/bmj.g7647 Khan, 2015, Pharmacokinetics and pharmacodynamics of oral P2Y12 inhibitors during the acute phase of a myocardial infarction: a systematic review Alexopoulos, 2012, Randomized assessment of ticagrelor versus prasugrel antiplatelet effects in patients with ST-segment-elevation myocardial infarction, Catheter. Cardiovasc. Interv., 5, 797, 10.1161/CIRCINTERVENTIONS.112.972323 Alexopoulos, 2015, Crushed versus integral tablets of ticagrelor in ST-segment elevation myocardial infarction patients: a randomized pharmacokinetic/pharmacodynamic study, Clin. Pharmacokinet. Beigel, 2013, Antiplatelet effect of thienopyridine (clopidogrel or prasugrel) pretreatment in patients undergoing primary percutaneous intervention for ST elevation myocardial infarction, Am. J. Cardiol., 112, 1551, 10.1016/j.amjcard.2013.07.010 Heestermans, 2008, Impaired bioavailability of clopidogrel in patients with a ST-segment elevation myocardial infarction, Thromb. Res., 122, 776, 10.1016/j.thromres.2008.01.021 Hobl, 2014, Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial, J. Am. Coll. Cardiol., 63, 630, 10.1016/j.jacc.2013.10.068 Hobl, 2015, Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers, Clin. Res. Cardiol. Kubica, 2015, Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial, Eur. Heart J. Orban, 2014, Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry, Thromb. Haemost., 112, 1190, 10.1160/TH14-06-0489 Osmancik, 2010, A comparison of the VASP index between patients with hemodynamically complicated and uncomplicated acute myocardial infarction, Catheter. Cardiovasc. Interv., 75, 158, 10.1002/ccd.22248 Parodi, 2013, Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (rapid activity of platelet inhibitor drugs) primary PCI study, J. Am. Coll. Cardiol., 61, 1601, 10.1016/j.jacc.2013.01.024 Parodi, 2015, Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention, Catheter. Cardiovasc. Interv., 8 Parodi, 2015, Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study, J. Am. Coll. Cardiol., 65, 511, 10.1016/j.jacc.2014.08.056 Aradi, 2010, Low platelet disaggregation predicts poor response to 150mg clopidogrel in patients with elevated platelet reactivity, Platelets, 21, 1, 10.3109/09537100903391015 Alexopoulos, 2012, Predictors of high on-treatment platelet reactivity early after clopidogrel loading in ST-elevation myocardial infarction, Circ. J., 76, 2183, 10.1253/circj.CJ-12-0173 Bonello, 2013, The impact of the environment on diseases and drugs, J. Am. Coll. Cardiol., 62, 513, 10.1016/j.jacc.2013.04.071 Alexopoulos, 2012, Ticagrelor versus prasugrel in acute coronary syndrome patients with high on-clopidogrel platelet reactivity following percutaneous coronary intervention: a pharmacodynamic study, J. Am. Coll. Cardiol., 60, 193, 10.1016/j.jacc.2012.03.050 Kumana, 1982, Absorption and antidysrhythmic activity of oral disopyramide phosphate after acute myocardial infarction, Br. J. Clin. Pharmacol., 14, 529, 10.1111/j.1365-2125.1982.tb02024.x Montalescot, 2014, Prehospital ticagrelor in ST-segment elevation myocardial infarction, N. Engl. J. Med., 371, 2339 Meine, 2005, Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative, Am. Heart J., 149, 1043, 10.1016/j.ahj.2005.02.010 <CAPITAL RELOAD.pdf>. Bhatt, 2013, Effect of platelet inhibition with cangrelor during PCI on ischemic events, N. Engl. J. Med., 368, 1303, 10.1056/NEJMoa1300815 Angiolillo, 2012, Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial, J. Am. Med. Assoc., 307, 265, 10.1001/jama.2011.2002 Mehilli, 2009, Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial, Circulation, 119, 1933, 10.1161/CIRCULATIONAHA.108.818617 De Luca, 2005, Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials, JAMA, 293, 1759, 10.1001/jama.293.14.1759 Stone, 2008, Bivalirudin during primary PCI in acute myocardial infarction, N. Engl. J. Med., 358, 2218, 10.1056/NEJMoa0708191 Cattabriga, 2007, Intravenous paracetamol as adjunctive treatment for postoperative pain after cardiac surgery: a double blind randomized controlled trial, Eur. J. Cardiothorac. Surg., 32, 527, 10.1016/j.ejcts.2007.05.017 Fassl, 2009, Anesthesia management for transapical transcatheter aortic valve implantation: a case series, J. Cardiothorac. Vasc. Anesth., 23, 286, 10.1053/j.jvca.2008.12.026 Remy, 2005, Effects of acetaminophen on morphine side-effects and consumption after major surgery: meta-analysis of randomized controlled trials, Br. J. Anaesth., 94, 505, 10.1093/bja/aei085